vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and 8X8 INC (EGHT). Click either name above to swap in a different company.

8X8 INC is the larger business by last-quarter revenue ($185.1M vs $121.8M, roughly 1.5× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs 2.8%, a 1.5% gap on every dollar of revenue. On growth, 8X8 INC posted the faster year-over-year revenue change (3.4% vs -1.4%). 8X8 INC produced more free cash flow last quarter ($19.1M vs $517.0K). Over the past eight quarters, 8X8 INC's revenue compounded faster (1.6% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

8x8, Inc. is an American provider of cloud communications and customer experience software for businesses. The company offers unified communications, contact center, and communications platform as a service (CPaaS) delivered via a cloud-based architecture. 8x8 is headquartered in Campbell, California. Its common stock trades on the Nasdaq under the ticker symbol EGHT, and the company is led by Samuel Wilson.

CLB vs EGHT — Head-to-Head

Bigger by revenue
EGHT
EGHT
1.5× larger
EGHT
$185.1M
$121.8M
CLB
Growing faster (revenue YoY)
EGHT
EGHT
+4.9% gap
EGHT
3.4%
-1.4%
CLB
Higher net margin
CLB
CLB
1.5% more per $
CLB
4.2%
2.8%
EGHT
More free cash flow
EGHT
EGHT
$18.6M more FCF
EGHT
$19.1M
$517.0K
CLB
Faster 2-yr revenue CAGR
EGHT
EGHT
Annualised
EGHT
1.6%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CLB
CLB
EGHT
EGHT
Revenue
$121.8M
$185.1M
Net Profit
$5.1M
$5.1M
Gross Margin
63.9%
Operating Margin
1.5%
5.2%
Net Margin
4.2%
2.8%
Revenue YoY
-1.4%
3.4%
Net Profit YoY
68.4%
EPS (diluted)
$0.11
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
EGHT
EGHT
Q1 26
$121.8M
Q4 25
$138.3M
$185.1M
Q3 25
$134.5M
$184.1M
Q2 25
$130.2M
$181.4M
Q1 25
$123.6M
$177.0M
Q4 24
$129.2M
$178.9M
Q3 24
$134.4M
$181.0M
Q2 24
$130.6M
$178.1M
Net Profit
CLB
CLB
EGHT
EGHT
Q1 26
$5.1M
Q4 25
$4.9M
$5.1M
Q3 25
$14.2M
$767.0K
Q2 25
$10.6M
$-4.3M
Q1 25
$-154.0K
$-5.4M
Q4 24
$7.4M
$3.0M
Q3 24
$11.7M
$-14.5M
Q2 24
$9.0M
$-10.3M
Gross Margin
CLB
CLB
EGHT
EGHT
Q1 26
Q4 25
20.8%
63.9%
Q3 25
22.0%
64.8%
Q2 25
20.3%
66.4%
Q1 25
19.5%
67.8%
Q4 24
17.8%
67.7%
Q3 24
20.5%
68.1%
Q2 24
21.2%
67.9%
Operating Margin
CLB
CLB
EGHT
EGHT
Q1 26
1.5%
Q4 25
11.5%
5.2%
Q3 25
15.6%
2.9%
Q2 25
11.7%
0.3%
Q1 25
3.6%
0.2%
Q4 24
11.0%
5.0%
Q3 24
14.7%
4.0%
Q2 24
12.3%
-0.8%
Net Margin
CLB
CLB
EGHT
EGHT
Q1 26
4.2%
Q4 25
3.6%
2.8%
Q3 25
10.6%
0.4%
Q2 25
8.2%
-2.4%
Q1 25
-0.1%
-3.1%
Q4 24
5.7%
1.7%
Q3 24
8.7%
-8.0%
Q2 24
6.9%
-5.8%
EPS (diluted)
CLB
CLB
EGHT
EGHT
Q1 26
$0.11
Q4 25
$0.11
$0.04
Q3 25
$0.30
$0.01
Q2 25
$0.22
$-0.03
Q1 25
$0.00
$-0.04
Q4 24
$0.15
$0.02
Q3 24
$0.25
$-0.11
Q2 24
$0.19
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
EGHT
EGHT
Cash + ST InvestmentsLiquidity on hand
$22.8M
$86.9M
Total DebtLower is stronger
$321.2M
Stockholders' EquityBook value
$275.1M
$142.9M
Total Assets
$587.7M
$661.5M
Debt / EquityLower = less leverage
2.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
EGHT
EGHT
Q1 26
$22.8M
Q4 25
$22.7M
$86.9M
Q3 25
$25.6M
$75.9M
Q2 25
$31.2M
$81.3M
Q1 25
$22.1M
$88.0M
Q4 24
$19.2M
$104.2M
Q3 24
$21.5M
$117.4M
Q2 24
$17.7M
$130.8M
Total Debt
CLB
CLB
EGHT
EGHT
Q1 26
Q4 25
$110.3M
$321.2M
Q3 25
$114.1M
$325.8M
Q2 25
$124.6M
$335.4M
Q1 25
$124.4M
$350.0M
Q4 24
$126.1M
$364.5M
Q3 24
$139.9M
$396.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
EGHT
EGHT
Q1 26
$275.1M
Q4 25
$266.0M
$142.9M
Q3 25
$271.3M
$133.2M
Q2 25
$261.3M
$128.2M
Q1 25
$253.4M
$122.2M
Q4 24
$246.6M
$113.0M
Q3 24
$250.7M
$109.8M
Q2 24
$240.3M
$104.6M
Total Assets
CLB
CLB
EGHT
EGHT
Q1 26
$587.7M
Q4 25
$584.0M
$661.5M
Q3 25
$591.4M
$670.8M
Q2 25
$602.1M
$684.3M
Q1 25
$591.5M
$683.2M
Q4 24
$585.1M
$698.2M
Q3 24
$600.5M
$740.1M
Q2 24
$597.8M
$755.7M
Debt / Equity
CLB
CLB
EGHT
EGHT
Q1 26
Q4 25
0.41×
2.25×
Q3 25
0.42×
2.45×
Q2 25
0.48×
2.62×
Q1 25
0.49×
2.86×
Q4 24
0.51×
3.23×
Q3 24
0.56×
3.61×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
EGHT
EGHT
Operating Cash FlowLast quarter
$4.0M
$20.7M
Free Cash FlowOCF − Capex
$517.0K
$19.1M
FCF MarginFCF / Revenue
0.4%
10.3%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
0.77×
4.07×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$43.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
EGHT
EGHT
Q1 26
$4.0M
Q4 25
$7.9M
$20.7M
Q3 25
$8.5M
$8.8M
Q2 25
$13.9M
$11.9M
Q1 25
$6.7M
$5.9M
Q4 24
$20.6M
$27.2M
Q3 24
$13.1M
$12.3M
Q2 24
$17.1M
$18.1M
Free Cash Flow
CLB
CLB
EGHT
EGHT
Q1 26
$517.0K
Q4 25
$5.0M
$19.1M
Q3 25
$6.5M
$7.7M
Q2 25
$10.4M
$11.5M
Q1 25
$3.9M
$5.5M
Q4 24
$17.4M
$26.8M
Q3 24
$10.4M
$11.1M
Q2 24
$14.3M
$17.8M
FCF Margin
CLB
CLB
EGHT
EGHT
Q1 26
0.4%
Q4 25
3.6%
10.3%
Q3 25
4.8%
4.2%
Q2 25
8.0%
6.3%
Q1 25
3.1%
3.1%
Q4 24
13.4%
15.0%
Q3 24
7.7%
6.1%
Q2 24
10.9%
10.0%
Capex Intensity
CLB
CLB
EGHT
EGHT
Q1 26
Q4 25
2.1%
0.9%
Q3 25
1.5%
0.6%
Q2 25
2.7%
0.2%
Q1 25
2.3%
0.2%
Q4 24
2.5%
0.3%
Q3 24
2.0%
0.7%
Q2 24
2.2%
0.2%
Cash Conversion
CLB
CLB
EGHT
EGHT
Q1 26
0.77×
Q4 25
1.61×
4.07×
Q3 25
0.60×
11.52×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
9.01×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

EGHT
EGHT

Services$179.7M97%
Other$5.4M3%

Related Comparisons